Chiesi USA, Inc.
Cornerstone Therapeutics is a specialty pharmaceutical company focused on commercializing products for the hospital and adjacent specialty markets. The company currently promotes four products; CARDENE®IV (nicardipine hydrochloride) Premixed Injection, PERTZYE® (pancrelipase) Delayed-Release Capsules, BETHKIS® (Tobramycin Inhalation Solution), and CUROSURF® (poractant alfa) Intratracheal Suspension. For information on Cornerstone or our products, please visit www.crtx.com.
1255 Crescent Green Drive